Study Analyzes Hormone Therapy in Younger Menopausal Women
Key points
- Could hormone therapy, when begun near the onset of menopause, prevent or delay the onset of atherosclerosis, more commonly called hardening of the arteries?
- That’s the question researchers hope to answer as part of the Kronnos Early Estrogen Prevention Study (KEEPS) under way at eight national medical centers, including Mayo Clinic.
- The January issue of Mayo Clinic Women’s HealthSource includes an overview of this initiative and why the answers will be important for women.
- In July 2002, the Women’s Health Initiative, a large study focusing on similar questions was halted when the data suggested that hormone therapy may increase the risk of heart attacks and strokes.
Could hormone therapy, when begun near the onset of menopause, prevent or delay the onset of atherosclerosis, more commonly called hardening of the arteries?
That’s the question researchers hope to answer as part of the Kronnos Early Estrogen Prevention Study (KEEPS) under way at eight national medical centers, including Mayo Clinic.
The January issue of Mayo Clinic Women’s HealthSource includes an overview of this initiative and why the answers will be important for women.
In July 2002, the Women’s Health Initiative, a large study focusing on similar questions was halted when the data suggested that hormone therapy may increase the risk of heart attacks and strokes. Researchers now believe that those results were influenced by the older ages of the women in the study. The average age was 63.
“There are reasons to believe that hormone therapy may be beneficial for preventing the early lesions of atherosclerosis in younger women, but ineffective or even harmful once the disease is established, as you find with older women,” says Virginia Miller, Ph.D., principal investigator of KEEPS at Mayo Clinic.
The five-year study is focusing on women within six months to three years of their last menstrual cycle. Participants are between ages 42 and 58.
“We know that estrogen reduces blood lipids, and we know that estrogen prevents osteoporosis,” says Dr. Miller. “If we can show that it also slows the progression of cardiovascular disease in recently menopausal women, it will really help women sort out the risks and benefits.”
Launched by the Kronos Longevity Research Institute, KEEPS includes 720 women. In addition to studying effects of estrogen on the arteries, researchers are studying the differences in safety and effectiveness of estrogen patches and pills.
Mayo Clinic Women’s HealthSource is published monthly to help women enjoy healthier, more productive lives. Revenue from subscriptions is used to support medical research at Mayo Clinic.
Source: Mayo Clinic
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →NewsHormone Therapy Boosts Sexual Interest But Not Memory
Hormone therapy in early post-menopause increases sexual interest, but does not improve memory, according to a study in the Sept. 25 issue of the journal Neurology. "Contrary to what we predicted, hormone therapy did…
26 September 2007
NewsLow-dose hormone therapy in the perimenopause: study
To evaluate the effects of low-dose hormone therapy (LD-HT) on bleeding pattern and vasomotor symptoms in perimenopausal women. Methods In a prospective, open-label study at an University clinic, 120 perimenopausal…
23 July 2007
NewsStudy to Clarify Safety, Effectiveness of Hormone Therapy During Menopause
When is the best time in a woman's reproductive history to start hormone therapy? How does estrogen therapy affect a woman's cognition and mood? What is the most beneficial form of estrogen? These are just a few…
